Insider Transactions

What NeuroOne Medical Technologies Corp's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

	3 months	12 months
Open-market buys	1	2
Sells	0	6
Total trades	1	22

Shares traded

	3 months	12 months
Acquired	33,333	229,655
Disposed	0	29,215
Net activity	+33,333	+200,441

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

All Buys Sells

Insider	Relation	Date	Transaction	Shares	Price	Value	Shares held
Wambeke David J.	Chief Business Officer	Aug 27	Open-market buy · P	+33,333	$2.01	+$67K	199,999
Christianson Mark	Market Development Director	Jun 30	Open-market sale · S	−10,000	$3.18	−$31.8K	20,692
Andrle Edward	Director	Apr 03	Grant / award · A	+41,929	—	—	133,932
Buckman Paul	Director	Apr 03	Grant / award · A	+41,929	—	—	178,733
Mathiesen Jeffrey S	Director	Apr 03	Grant / award · A	+41,929	—	—	156,343
Mills Jason Richard	Director	Apr 03	Grant / award · A	+41,929	—	—	49,687
Christianson Mark	Business Development Director	Mar 31	Withheld — tax / exercise cost · F	−253	$0.78	−$197	198,667
Rosa David A	CEO and President	Mar 31	Withheld — tax / exercise cost · F	−2,458	$0.78	−$1.91K	1,080,132
Mertens Steve	Chief Technology Officer	Mar 31	Withheld — tax / exercise cost · F	−906	$0.78	−$704	152,141
Christianson Mark	Business Development Director	Mar 30	Open-market sale · S	−15,363	$0.74	−$11.4K	198,920
Christianson Mark	Business Development Director	Mar 13	Open-market sale · S	−100	$0.80	−$80	214,283
Christianson Mark	Business Development Director	Mar 12	Open-market sale · S	−817	$0.80	−$654	214,383
Christianson Mark	Business Development Director	Mar 11	Open-market sale · S	−2,109	$0.80	−$1.69K	215,200
Christianson Mark	Business Development Director	Mar 10	Open-market sale · S	−11,611	$0.80	−$9.29K	217,309
Wambeke David J.	Chief Business Officer	Mar 01	Open-market buy · P	+1,000,000	$0.67	+$670K	1,000,000
Christianson Mark	Business Development Director	Feb 18	Withheld — tax / exercise cost · F	−1,812	$0.68	−$1.23K	228,920
Rosa David A	CEO and President	Feb 18	Withheld — tax / exercise cost · F	−71,325	$0.68	−$48.5K	1,082,590
Mertens Steve	Chief Technology Officer	Feb 18	Withheld — tax / exercise cost · F	−7,376	$0.68	−$5.02K	153,047
Christianson Mark	Business Development Director	Dec 31	Withheld — tax / exercise cost · F	−253	$0.76	−$192	230,732
Rosa David A	CEO and President	Dec 31	Withheld — tax / exercise cost · F	+2,458	$0.76	+$1.86K	1,153,915

Page 1 of 10 · showing the 20 most recent Sign up free to view all 181 transactions and filter by insider →

Comments